Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: IP Group, Millennium & Copthorne Lead FTSE 350 Risers

Fri, 21st Feb 2014 11:57

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Royal Bank of Scotland Group, up 2.4%. The bank is preparing a dramatic retrenchment that would see it become a much smaller UK retail and commercial bank, a move that is expected to see staff numbers slashed by at least 30,000 in the coming years, the Financial Times has reported, citing people familiar with the bank's plans. In the wake of the news, Shore Capital has reiterated its Buy recommendation, saying that the move is likely to result in a, "smaller but more efficient, higher return and less risky bank."

GlaxoSmithKline, up 0.6%. The pharmaceuticals company said that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the drug. Anoro, a combination treatment for the disease, is also undergoing regulatory review.

Royal Dutch Shell, up 0.6%. The European oil giant said it has reached a binding agreement to sell its Australia downstream businesses, excluding Aviation, to Dutch-owned oil trader Vitol for a total transaction value of around AUD2.9 billion or USD2.6 billion. The deal is expected to close in 2014.

-------

FTSE 100 - LOSERS

Smiths Group, down 2.1%. UBS has downgraded the company to Sell from Neutral, lowering its price target to 1,340.00 pence, from 1,450.00p. UBS analyst Mark Fielding says that the company came out in the "bottom quartile" in its sector quality analysis looking at historical performance and that, a three year earnings per share compound annual growth rate of approximately 5% is at the low-end of the group.

-------

FTSE 250 - WINNERS

IP Group, up 9.3%. The firm said that its portfolio company, Xeros Ltd, intends to float on AIM to raise funds to bring its patented polymer bead cleaning system to the laundry market. The funds raised in the AIM initial public offering are expected to support Xeros in rolling out in the commercial laundry market, and to fund the research and development process through to commercialisation in other identified applications, not least in domestic laundry. IP Group has an undiluted beneficial stake of 14.6% in Xeros.

Millennium & Copthorne Hotels, up 4.7%. The firm reported a pretax profit of GBP167.7 million for the fourth quarter of 2013, up from only GBP54.2 million a year earlier, and a pretax profit of GBP263.6 million for the year as a whole, compared with a profit of GBP171.3 million in 2012. Group revenue increased to the record level of GBP1.04 billion in 2013, due to a GBP273.7 million revenue boost from the Glyndebourne development in Singapore. It has sold 147 out of 150 apartments built on the site of the former Copthorne Orchid Hotel in Singapore.

Informa, up 1.5%. The business media and events company pledged to deliver further growth in adjusted earnings per share in 2014, as it reported improved revenue and pretax profit for 2013 in the first set of results under new Chief Executive Stephen Carter. Its pretax profit in 2013 was GBP115.7 billion, up from GBP70.4 billion in 2012, with revenues increasing to GBP1.13 billion, from GBP1.11 billion. It maintained its final dividend at 12.50 pence, bringing its total dividend to 18.90 pence, up from 18.50 pence in the previous year. The new CEO said a key objective for Informa in 2014 will be managing the transition in leadership as smoothly and effectively as possible. He set out two major challenges for Informa: addressing the shift in technology happening in Informa's market, and returning the company's Business Intelligence division to growth.

-------

FTSE 250 - LOSERS

Vesuvius, down 2.8%. UBS has initiated the company with a Sell rating and price target of 440.00p. UBS says that while the company is not expensive on headline valuations, in the context of its engineering sector coverage it sees a, "significant sector valuation discount as justified."

-------

AIM - WINNERS

Churchill Mining, up 35%. The thermal coal producer said it expects to receive a ruling on its international arbitration claim against the Republic of Indonesia on February 24. The company added that a temporary suspension in trading of the Company's shares on AIM will take effect on February 24 and the shares will restart trading following a notification of the ruling.

Planet Payment, up 8.9%. The company's shares have jumped after it said it had applied for 21,892 new shares to be admitted to trading on AIM in accordance with the exercise of warrants. The shares are to be issued to the holder of a warrant issued in 2009, following the exercise of warrants at an exercise price of 45 US cents per share.

Pentagon Protection, up 7.9%. The firm said that it swung to a pretax profit as revenue more than doubled in its last financial year. It reported a pretax profit of GBP391,415 for the year to September 30, 2013, compared with a pretax loss of GBP523,474 a year earlier, as it saw revenue more than double to GBP5.4 million, from GBP2.0 million.

-------

AIM - LOSERS

The Real Good Food Company, off 28%. The baker and sugar producer has said it is in a pricing dispute with the sugar subsidiary of Associated British Foods. The company said it is unlikely that the pricing dispute with British Sugar will be resolved in the near future, and it will hit earnings both this year and next year. British Sugar is a major supplier to The Real Good Food Company's Napier Brown non-refining sugar distribution business.

Airea, down 27%. The group said that pretax profit and revenues fell during the half-year, as it continues restructuring plans amid ongoing "hostile market conditions." Revenue for the six months to December 31, 2013, fell to GBP11.6 million from GBP13.5 million a year earlier, and operating profit followed suit, coming in at GPB222,000, down from GBP359,000 in 2012. Pretax profit declined to GBP24,000 from GBP270,000 last year and from GBP533,000 in the previous six month period.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.